Search Results - "Nemeth, Joanne"

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study by Utsugisawa, Kimiaki, Kissel, John T, O'Brien, Fanny, Lamont, Phillipa, Roberts, Leslie, De Mey, Katrien, Tilkin, Petra, Alves de Siqueira Carvalho, Alzira, Paiva, Gabriel, Prando, Natalia, Souza, Iandra, Campbell, Natasha, Blackmore, Derrick, Autzen, Anne Mette, Harrison, Tuula, Moutarde, Julie, Le Masson, Gwendal, Wilson, Amy, Fricke, Karin, Horvath, Melinda, Matolcsi, Judit, Szabadosne, Brigitta, Vecsei, Laszlo, Konyane, Monika, Troili, Fernanda, Di Pasquale, Antonella, Filla, Alessandro, Campanella, Angela, Inghilleri, Maurizio, Fionda, Laura, Gabriele, Maria, Salvatore Caramma, Andrea, Kanzaki, Akiko, Jingu, Maki, Yoshimura, Shunsuke, Kobashikawa, Tomomi, Yamashita, Yumi, Kawamura, Tomohiro, Higuchi, Eriko, Osakada, Kaori, Hisahara, Shin, Suzuki, Shuichiro, Ogasawara, Junichi, Shinozaki, Hirokazu, Gibson, Tamar, Keijzers, Maria Johanna, Kim, Byung-Jo, Ra, HyeJin, Kim, Byoung Joon, Lee, JiEun, Kim, Seung Min, Kim, Yool-hee, Lee, Hyung Seok, Yarmoschuk, Asya, Nesterova, Yulia, Fernandez-Fournier, Mireya, Hietala, Albert, Andersson, Blanka, Boz, Cavit, Erdem-Ozdamar, Sevim, Terzi, Murat, Gollogly, Jakit, Smalley, Nicole, Silvestri, Nicholas, Loor, John, Pascuzzi, Robert, Snook, Riley, Carter, Cynthia, Levine-Weinberg, Mark, Simpson, Ericka, Kaur, Harpreet, Crabtree, Brigid, Taber, Sandra, Gilchrist, James, Darnell, Taylor, Goyal, Neelam, Sakamuri, Sarada, Jones, Floyd, Alsharabati, Mohammad, Butters, Janelle, Goyal, Namita, Garcia, Sonia, Echevarria, Laura, Pulley, Michael, Shabbir, Yasmeen, Gutmann, Laurie, Gutmann, Ludwig, Hafer-Macko, Charlene, Chopra, Manisha, Kaufman, Jacob, McClain, Terry, Harvey, Brittany, Huynh, Kristin, Droker, Brian, Weiss, Michael, Downing, Sharon, Bernitsas, Evanthia, Kumar Sriwastava, Shitiz, Jia, Kelly, Patwa, Huned

“…Complement is likely to have a role in refractory generalised myasthenia gravis, but no approved therapies specifically target this system. Results from a…”
Get full text

Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis by Illa, Isabel, Wang, Jing Jing, Garcia, Alejandra Dalila, de Koning, Kathy, Stevens, Olivier, Pozo, Marina, Souza Duca, Luciana, Guerreiro, Alexandre, Carrara, Fernanda, Siddiqi, Zaeem, Kurkova, Barbora, Pitha, Jiri, Wolfova, Marcela, Pedersen, Jane, Oksaranta, Olli, Jakab, Gedeonne, Antonini, Giovanni, Di Pasquale, Antonella, Costabile, Teresa, Marsili, Angela, Bonanno, Silvia, Camera, Giorgia, Pasanisi, Maria, Gabriele, Maria, Uzawa, Akiyuki, Matsushita, Takuya, Kikutake, Keiko, Nakamura, Yumiko, Samukawa, Makoto, Mitazaki, Teiichiro, Yoshimura, Shunsuke, Tsurumaru, Masako, Makamori, Masayuki, Takahashi, Masanori, Hasuike, Tomoya, Kobayashi, Hisako, Osakada, Kaori, Imai, Tomihiro, Tsuda, Emiko, Murahara, Takashi, Suzuki, Shuichiro, Uwasa, Kaori, Min, Ju-Hong, Koh, Da Yoon, Kwon, JuYoung, Hwang, Ji Ye, Kim, Miri, Jung, JinWoo, Shin, Ha Young, Shin, Miju, Lazaro, Ana, Diez Tejedor, Exuperio, Salvado, Maria, Mazuela, Gonzalo, Diaz-Manera, Jordi, Piehl, Fredrik, Hietala, Albert, Sengun, Ihsan, Bekircan‐Kurt, Can Ebru, Orsel, Gulsah, Semiz, Cansu, Veske, Adife, Gollogly, Jakit, Sokratous, Giannis, Sohail, Faisal, Arndt, Heike, Amato, Anthony, Salajegheh, Mohammed, Patrick, Kara, Bravver, Elena, Cunningham, Scott, Schommer, Clara, Carnes, Donna, Bodkin, Cynthia, Carter, Cynthia, Jeffery, Dennis, Chelnick, Sharon, Marburger, Tessa, Gilchrist, James, Andoin, Angela, Seelback, Jenna, Bhavaraju-Sanka, Ratna, Alsharabati, Mohammad, Lu, Liang, Rosenfeld, Jeffrey, Pulley, Michael, Shah, Jaimin, Gutmann, Ludwig, Pasnoor, Mamatha, Jenci, Nicole, Locheke, Jerry, Fondaw, Alex, Sharma, Khema, Steele, Julie, Chopra, Manisha, Katzin, Lara, Beydoun, Said, Waheed, Waqar, Distad, Jane, Robeson, Kimberly

“…ABSTRACT Introduction: Eculizumab is effective and well tolerated in patients with antiacetylcholine receptor antibody‐positive refractory generalized…”
Get full text

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results by Goetz, Christopher G., Tilley, Barbara C., Shaftman, Stephanie R., Stebbins, Glenn T., Fahn, Stanley, Martinez-Martin, Pablo, Poewe, Werner, Sampaio, Cristina, Stern, Matthew B., Dodel, Richard, Dubois, Bruno, Holloway, Robert, Jankovic, Joseph, Kulisevsky, Jaime, Lang, Anthony E., Lees, Andrew, Leurgans, Sue, LeWitt, Peter A., Nyenhuis, David, Olanow, C. Warren, Rascol, Olivier, Schrag, Anette, Teresi, Jeanne A., van Hilten, Jacobus J., LaPelle, Nancy

“…We present a clinimetric assessment of the Movement Disorder Society (MDS)‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS). The…”
Get full text

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension by Muppidi, Srikanth, Wilken, Miguel, Saba, Juliet, Bettini, Mariela, De Bleecker, Jan, Van den Abeele, Guy, Mahieu, Délphine, Stevens, Olivier, Pozo, Marina, Martineli Torres, Debora Dada, Duran, Gustavo, Ferreira, Luciana, de Cassia Santos, Aline, Carrara, Fernanda, Pitha, Jiri, Jurajdova, Ivana, Wolfova, Marcela, Vissing, John, Ostergaard Autzen, Anne Mette, Erälinna, Juha-Pekka, Horvath, Melinda, Szabadosne, Brigitta, Konyane, Monika, Morino, Stefania, Marano, Enrico, Bonanno, Silvia, Camera, Giorgia, Pasanisi, Maria, Uzawa, Akiyuki, Kobayashi, Eri, Samukawa, Makoto, Suzuki, Hidekazu, Miyawaki, Eriko, Kobayashi, Hisako, Osakada, Kaori, Miyazaki, Teiichiro, Yoshimura, Shunsuke, Tsurumaru, Masako, Hisahara, Shin, Suzuki, Shuichiro, Uwasa, Kaori, van der Kooi, Anneke, Kang, Hoo Nam, Lee, HyeLim, Park, SangAe, Kim, Miri, Shin, Miju, Palacios, Natalia Julia, Santamaria, Valentina Velez, Illa, Isabel, Querol Gutiérrez, Luis Antonio, Vidal, Nuria, Salcedo, Pilar Gomez, Fernandez-Fournier, Mireya, Ruiz, Pedro Lopez, Ozcelik, Pinar, Caliskan, Yagmur, Cavus, Hakan, Torane, Pravin, Brown, Claire, Shah, Amna, Sathasivam, Sivakumar, Watling, Dave, Toska, Shirli, Silvestri, Nicholas, Zakalik, Karen, Engel, Marguerite, Plevka, Sarah, Burdette, Maryanne, Kramer, Megan, Snook, Riley, Mosmiller, Betsy, Carter, Cynthia, McKinnon, Jonathan, Haar, Laura, Sattar, Nadia, Freimer, Miriam, Pineda, Colleen, Kaur, Harpreet, Elsayed, Mona, Golden, Laura, Goyal, Neelam, Paulose, Shirley, Jones, Floyd, Mathew, Veena, Echevarria, Laura, Aranke, Shachie, Berger, Alan Ross, Nance, Christopher, Barohn, Richard, Johns, Kathryn, Hafer-Macko, Charlene, Naunton, Kerry, McClain, Terry, Huynh, Kristin, Doan, Victor, Tran, Anh, Nowak, Richard, Kumar, Aditya, Patwa, Huned

“…To evaluate whether eculizumab helps patients with anti-acetylcholine receptor-positive (AChR+) refractory generalized myasthenia gravis (gMG) achieve the…”
Get full text

Community Health Simulation with a Standardized Patient: Exploring the Experience by Herron, Elizabeth K., Nemeth, Joanne, Powers, Kelly A.

“…Nursing students must be prepared to care for patients in community settings; however, limited evidence exists on community health nursing simulations with a…”
Get full text

‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab by Vissing, John, Jacob, Saiju, Fujita, Kenji P., O’Brien, Fanny, Howard, James F.

“…Background The efficacy and tolerability of eculizumab were assessed in REGAIN, a 26-week, phase 3, randomized, double-blind, placebo-controlled study in…”
Get full text

Eculizumab improves fatigue in refractory generalized myasthenia gravis by Andersen, Henning, Mantegazza, Renato, Wang, Jing Jing, O’Brien, Fanny, Patra, Kaushik, Howard, James F.

“…Purpose To evaluate the effect of eculizumab on perceived fatigue in patients with anti-acetylcholine receptor antibody-positive, refractory, generalized…”
Get full text

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study by Nowak, Richard J., Mozaffar, Tahseen, Wilken, Miguel, Saba, Juliet, Bettini, Mariela, De Bleecker, Jan, Van den Abeele, Guy, Mahieu, Délphine, Stevens, Olivier, Geraldo, Jordana Gonçalves, Pozo, Marina, Volpe, Luciana Renata Cubas, Ferreira, Luciana, Cassia Santos, Aline, Andrade, Ana Carolina Amaral, Carrara, Fernanda, Junkerova, Jana, Krogh, Susanne, Autzen, Anne Mette Ostergaard, Erälinna, Juha‐Pekka, Oksaranta, Olli, Szabadosne, Brigitta, Antonini, Giovanni, Puorro, Giorgia, Lopergolo, Diego, Onesti, Emanuela, Frasca, Vittorio, Kanzaki, Akiko, Shimpo, Misa, Morikawa, Miyuki, Shiraishi, Hirokazu, Asada, Shizuka, Amamoto, Shoko, Takada, Kazumi, Suzuki, Yasushi, Akiyama, Tetsuya, Narikawa, Koichi, Fukuda, Yusuke, Sato, Miwako, Nakamori, Masayuki, Yamamoto, Daisuke, Ishiyama, Naoko, Lee, Chang Nyoung, Choi, Mi Song, Jeong, Ha‐Neul, Lee, Hyung Seok, Hwang, Eun Bi, Visser, Marianne, Casasnovas, Carlos, Aguilo, Maria Antonia Alberti, Tejedor, Exuperio Diez, Rivera, Francisco Javier Rodriguez, Fernandez‐Fournier, Mireya, Sastre, Maria, Carbonell, Josep Gamez, Piehl, Fredrik, Hietala, Albert, Sengun, Ihsan, Orsel, Gulsah, Semiz, Cansu, Cavdar, Tugce Kirbas, Sohail, Faisal, Arndt, Heike, Salajegheh, Mohammed, Bravver, Elena, Plevka, Sarah, Guptill, Jeffrey, Hobson‐Webb, Lisa, Pascuzzi, Robert, Mosmiller, Betsy, Ventura, Nicholas, Carter, Cynthia, Sattar, Nadia, Daniels, Kevin, Jeffery, Dennis, Khoury, Julie, Dimitrova, Diana, Seelbach, Jenna, Paulose, Shirley, Bhavaraju‐Sanka, Ratna, Jones, Floyd, Roy, Gulmohor, Mathew, Veena, Echevarria, Laura, Shabbir, Yasmeen, Barohn, Richard, Glenn, Melanie, Johns, Kathryn, Naunton, Kerry, Bilsker, Martin, Karam, Chafic, Vu, Tuan, Gong, Hui, Karimi, Sanaz, Akhter, Salma, Strom, Susan, Bertorini, Tulio, Henderson, Kendrick, Wheeler, Lauren, Nye, Joan

“…Introduction/Aims Individuals with refractory generalized myasthenia gravis (gMG) who have a history of rituximab use and experience persistent symptoms…”
Get full text

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study by Suzuki, Hidekazu, Fujita, Kenji P., Rugiero, Marcelo, Bettini, Mariela, Garcia, Alejandra Dalila, Smetcoren, Charlotte, Van Daele, Sien, Verjans, Sarah, Melo, Ana Paula, Rocha, Rosana, Gonçalves Geraldo, Jordana, Otavio Maia Gonçalves, Luiz, Renata Cubas Volpe, Luciana, Amaral Andrade, Ana Carolina, Cavalcante Lino, Valeria, Carrara, Fernanda, Siddiqi, Zaeem, Phan, Cecile, Junkerova, Jana, Zapletalova, Olga, Wolfova, Marcela, Eriksson, Jaana, Matolcsi, Judit, Garibaldi, Matteo, Saccà, Francesco, Mantegazza, Renato, Bonanno, Silvia, Camera, Giorgia, Pasanisi, Maria, Matsuse, Dai, Nakamura, Yumiko, Futono, Kazumi, Morikawa, Miyuki, Miyawaki, Eriko, Motomura, Masakatsu, Maeda, Yasuko, Takada, Kazumi, Akiyama, Tetsuya, Fukuda, Yusuke, Sato, Miwako, Kawamura, Tomohiro, Kobayashi, Hisako, Tsuda, Emiko, Hayashi, Takashi, Murahara, Takashi, Suzuki, Shuichiro, Noshiro, Mayuko, Yasuda, Ikuko, Homedes-Pedret, Christian, Julia Palacios, Natalia, Diez Tejedor, Exuperio, Rodriguez de Rivera, Francisco Javier, Cortes Vicente, Elena, Querol Gutierrez, Luis Antonio, Bjarbo, Lena, Meherremova, Arzu, Balkan, Bengu, Ugur, Muzeyyen, Aydinlik, Seda, Cavus, Hakan, Kutlu, Ayse, Veske, Adife, Sokratous, Giannis, Shah, Amna, Arndt, Heike, Wolfe, Gil, Patrick, Kara, Forshew, Dallas, Bravver, Elena, Hobson-Webb, Lisa, Beck, Kate, Pascuzzi, Robert, Kincaid, John, Kelley, Andrea, Ho, Doreen, Scala, Stephanie, Herbert, Carol, Weiner, Elaine, Marburger, Tessa, Dimitrova, Diana, Seelback, Jenna, Alsharabati, Mohammad, Nozaki, Kenkichi, Minton, Brian, Rosenfeld, Jeffrey, Shah, Jaimin, Smith, Lisa, Jerath, Nivedita, Swenson, Andrea, Dimachkie, Mazen, Wang, Yunxia, Johns, Kathryn, Hafer-Macko, Charlene, Young, Valerie, Sheldon, Danielle, Katzin, Lara, Droker, Brian, Lin, Frank, Pokala, Krishna, Weiss, Michael

“…The terminal complement inhibitor eculizumab was shown to improve myasthenia gravis-related symptoms in the 26-week, phase 3, randomized, double-blind,…”
Get full text

Community Health Simulation with a Standardized Patient: Exploring the Experience by Herron, Elizabeth K, Nemeth, Joanne, Powers, Kelly A

“…Background: Nursing students must be prepared to care for patients in community settings; however, limited evidence exists on community health nursing…”
Get full text

Adaptive Design Single Center Phosphodiesterase Type 4 ( PDE4 ) Inhibitor – Ibudilast ( MN-166-ALS-1201 ) Phase 1b / 2a Clinical Trial Double - Blind ( DB ) with Open Label Extension (OLE) [ NCT02238626 ] for Amyotrophic Lateral Sclerosis ( ALS ) Patients [ 1 ] Not Requiring Non-Invasive Ventilation ( no NIV ) up to 5 years ( Early Cohort – EC ) and [ 2 ] Requiring Non-Invasive Ventilation ( NIV ) up to 10 years ( Advanced NIV Cohort – ANC ) from Disease Onset – Report of Clinical Trial DB, OLE by Brooks, Benjamin Rix, Bravver, Elena, Sanjak, Mohammed, Langford, Velma, Moore, Linda, Smith, Nicole, Lucas, Nicole, Nichols, Mindy, Lary, Cynthia, Newell-Sturdivant, Allison, Nemeth, Joanne, Russo, Priscilla, Brandon, Nicol, Ranzinger, Lisa, Burdette, Maryanne, Wright, Kathryn, Ward, Amber, Holsten, Scott, Fischer, Michael, Hillberry, Rachel, Bockenek, William, Lindblom, Scott S, Bringardner, Benjamin, Sachar, David, Dojillo, Joanna, Matsuda, Kazuko, Iwaki, Yuichi

“…Abstract only…”
Get full text

Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis by Andersen, Henning, Mantegazza, Renato, Wang, Jing Jing, O’Brien, Fanny, Patra, Kaushik, Howard, James F.

“…The article “Eculizumab improves fatigue in refractory generalized myasthenia gravis”, written by “Henning Andersen, Renato Mantegazza, Jing Jing Wang, Fanny…”
Get full text

Amyotrophic Lateral Sclerosis (ALS) with Laboratory Abnormalities of Unknown Significance (LAUS) --Where Does It Begin and Where Does It End? (P4.144) by Brooks, Benjamin, Bravver, Elena, Langford, Velma, Alwan, Mohamed, Smith, Nicole, Lucas, Nicole, Nichols, Mindy, Belcher, Sharon, Lary, Cynthia, Nemeth, Joanne, Russo, Priscilla, Wright, Kathryn, Ward, Amber, Holsten, Scott, Fischer, Michael, Bockenek, William, Desai, Urvi, Lindblom, Scott C, Pacicco, Thomas, Sanjak, Mohammed

“…Abstract only…”
Get full text

Consistent improvement with eculizumab across muscle groups in myasthenia gravis by Mantegazza, Renato, Chaves, Marcelo, Vidal, Gonzalo, Mercelis, Rudy, Van Damme, Philip, Vandenbussche, Nicolas, Vynckier, Jan, Tilkin, Petra, Feder, David, Bezerra Rosa, Bruno, Paiva, Gabriel, Fernanda Butinhao, Cristiani, Paula Macagnan, Ana, Pinto, Graziela, Souza Bulle Oliveira, Acary, Annes, Marcelo, Cavalcante Lino, Valeria, Pinto, Wladimir, Assis, Natália, Fernandes, Patrícia, Narayan, Jeffrey, Blackmore, Derrick, Vohanka, Stanislav, Chmelikova, Magda, Toncrova, Stanislava, Kurkova, Barbora, Zapletalova, Olga, Pedersen, Jane, Erälinna, Juha‐Pekka, Harrison, Tuula, Rozsa, Csilla, Di Pasquale, Antonella, Garibaldi, Matteo, Gori, Maria, Marano, Enrico, Bonanno, Silvia, Camera, Giorgia, Pasanisi, Maria, Uzawa, Akiyuki, Kobayashi, Eri, Samukawa, Makoto, Suzuki, Hidekazu, Miyawaki, Eriko, Kobayashi, Hisako, Osakada, Kaori, Miyazaki, Teiichiro, Yoshimura, Shunsuke, Tsurumaru, Masako, Hisahara, Shin, Kawamata, Jun, Ishiyama, Yoko, Noshiro, Mayuko, Takeyama, Rumi, Lee, HyeLim, Lee, JiEun, Park, SangAe, Homedes‐Pedret, Christian, Diaz‐Manera, Jordi, Antonio Querol Gutiérrez, Luis, Lopez Ruiz, Pedro, Rodriguez de Rivera, Francisco Javier, Meherremova, Arzu, Pinar Acar, Nazire, Kazim Onar, Musa, Davies, Debbie, Wolfe, Gil, Sanjak, Mohammed, Massey, Janice, Kincaid, John, Chaudhry, Vinay, Vytopil, Michal, Jara, Jordan, Weiner, Elaine, McKinnon, Naya, McKenna, Kaitlyn, Kohlrus, Stephanie, Darnell, Taylor, Lokaitis, Barbara, Padilla, Patricia, Hopkins, Steve, Nozaki, Kenkichi, Mumfrey‐Thomas, Sandi, Woodall, Amy, Maqsood, Fatima, Minton, Brian, Garcia, Rebekah, Ross Berger, Alan, Shabbir, Yasmeen, Gutmann, Ludwig, Jenci, Nicole, Fondaw, Alex, Sharma, Khema, Steele, Julie, Hart, Adam, Waheed, Waqar, Weiss, Michael, Downing, Sharon, Arnold, Thomas, Hewlett, Jasmine, Dicapua, Daniel

“…Objective To assess whether eculizumab, a terminal complement inhibitor, improves patient‐ and physician‐reported outcomes (evaluated using the myasthenia…”
Get full text

Randomized phase 2 trial of NP001–a novel immune regulator: Safety and early efficacy in ALS by Miller, Robert G, Block, Gilbert, Barohn, Richard J, Cudkowicz, Merit, Zhang, Jane R, McGrath, Michael S, Appel, Stan H, Katz, Jonathan, Kushner, Giovanna, Wong, Cynthia, Akers, Amy, Zayas-Bazan, Thais, McCoy, Shelly, Goyal, Neelam, Harris, Will, Gonella, Marie, Brooks, Benjamin R, Bravver, Elena, Sanjak, Mohammed, Ward, Amber L, Mehrizi, Amir, Belfiore, Mark, Lary, Cynthia, Nemeth, Joanne, Conway, Jill, Holsten, Scott, Shue, Jamie, Mitsumoto, Hiroshi, Youngman, Regina, Lee, Yei-won, Dalton, Kate, Bedlack, Richard S, Morgenlander, Joel Charles, Boyette, Candace Lee, Grace, Karen L, Thomas Hickey, Patrick, Perry-Trice, Peggy, Berry, James, Atassi, Nazem, Boylan, Kevin, Kennelly, Kathleen, DeSaro, Pamela, Johnston, Amelia, Huser, Angela, Fuqua, Paula, Staggs, Kristin, Babcock, Lorraine, Kryston, Thomas, Bosch, E Peter, Verheijde, Josephus L, Grover, Yvvonne, Lee, Michael S, Musil, Danette J, Whiteman, Dana, Simpson, Ericka P, Pleitez, Milvia Y, Lay, Luis F, Schwartz, Thomas, Blanton, Linda, Lai, Eugene C, Berry, Nicole, Khan, Sara, Chowdhury, Nabi, Goslin, Kimberly, Carter, Gregory T, Ann Kovarik, Mary, Simionescu, Laura, Reale, Melissa A, Markis, Katie, Money, Kristina, Boevin, Travis, Lava, Neil, Glass, Jonathan D, Polak, Meraida, Shaw, Latoya, Bordeau, Jane, Rogers, Susan, Ferguson, Susan, Kelly, Crystal, Mozaffar, Tahseen, Ramsey, Gladys, Tully, Patricia A, Alvarez, Rebecca, Barohn, Richard, Dimachkie, Mazen M, Pasnoor, Mamatha, Herbelin, Laura, Kasarskis, Edward J, Dotson, William F, Sitzlar, Stephen C, Tandy, Tammy, Carrico, Jeffery, Rice, Linda, Chamblin, Lisa, Townsend, Janet, Hanley-Borgia, Lisa, Vanderpool, Kathryn E, Taylor, Deborah G, Hutchinson, Jan, King, Jason T

“…OBJECTIVE:To assess the safety, tolerability, and preliminary efficacy of NP001, a novel immune regulator of inflammatory monocytes/macrophages, for slowing…”
Get full text

Serum Creatinine, a Biomarker for Muscle Mass in Amyotrophic Lateral Sclerosis (ALS), Predicts Loss of Ambulation Measured by ALS Functional Rating Scale-Revised Walking Item Score (ALSFRS-Rw) (P4.085) by Brooks, Benjamin, Fischer, Michael, Sanjak, Mohammed, Holsten, Scott, Kandinov, Boris, Bockenek, William, Bravver, Elena, Desai, Urvi, Story, John Scott, Pacicco, Thomas, Lindblom, Scott, Langford, Velma, Wright, Kathryn, Ward, Amber, Lucas, Nicole, Smith, Nicole, Nichols, Mindy, Lary, Cynthia, Nemeth, Joanne, Russo, Priscilla

“…Abstract only…”
Get full text

Safety and Tolerability of Systemic Beta-2-Adrenergic Agonist[Albuterol] as Pharmacological Therapy in Non-Invasive Ventilation[ NIV ]-supported Amyotrophic Lateral Sclerosis[ALS]Patients with Chronic Respiratory Failure (P4.079) by Brooks, Benjamin, Kandinov, Boris, Langford, Velma, Lindblom, Scott, Sanjak, Mohammed, Wright, Kathryn, Ward, Amber, Holsten, Scott, Fischer, Michael, Lucas, Nicole, Smith, Nicole, Nichols, Mindy, Lary, Cynthia, Nemeth, Joanne, Russo, Priscilla, Bockenek, William, Bravver, Elena, Desai, Urvi, Story, John Scott, Pacicco, Thomas

“…Abstract only…”
Get full text

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Six-Month Clinical Trial Followed by an Open-Label Extension to Evaluate the Safety, Tolerability and Clinical Endpoint Responsiveness of the Phosphodiesterase Type 4 (PDE4) Inhibitor Ibudilast (MN-166) in Subjects with Amyotrophic Lateral Sclerosis (ALS) - STEP-IBUDILAST-ALS-DB-OLE-1 (S50.005) by Brooks, Benjamin, Bravver, Elena, Sanjak, Mohammed, Langford, Velma, Lary, Cynthia, Alwan, Mohamed, Nemeth, Joanne, Russo, Priscilla, Smith, Nicole, Lucas, Nicole, Nichols, Mindy, Belcher, Sharon, Wright, Kathryn, Ward, Amber, Holsten, Scott, Fischer, Michael, Bockenek, William, Desai, Urvi, Lindblom, Scott C, Pacicco, Thomas, Matsuda, Kazuko, Dojillo, Joanna

“…Abstract only…”
Get full text

A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Six-Month Clinical Trial Followed by an Open-Label Extension to Evaluate the Safety, Tolerability and Clinical Endpoint Responsiveness of the Phosphodiesterase Type 4 (PDE4) Inhibitor Ibudilast (MN-166) in Subjects with Amyotrophic Lateral Sclerosis (ALS) - STEP-IBUDILAST-ALS-DB-OLE-1 (I8-1B) by Brooks, Benjamin, Bravver, Elena, Sanjak, Mohammed, Langford, Velma, Lary, Cynthia, Alwan, Mohamed, Nemeth, Joanne, Russo, Priscilla, Smith, Nicole, Lucas, Nicole, Nichols, Mindy, Belcher, Sharon, Wright, Kathryn, Ward, Amber, Holsten, Scott, Fischer, Michael, Bockenek, William, Desai, Urvi, Lindblom, Scott C, Pacicco, Thomas, Matsuda, Kazuko, Dojillo, Joanna

“…Abstract only…”
Get full text